Delivery Order SPE2DB24D2109-SPE2DB25FHXVA
- Not listed
- The Defense Logistics Agency awarded a $17,181.16 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of October 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $17,181.16 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units. This is a firm fixed-price delivery order with an ultimate completion date of October 14, 2025, and no set-aside designation was utilized. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,220.86 by the Defense Logistics Agency on September 25, 2025, with completion targeted for October 17, 2025. The contract, awarded on a firm fixed-price basis with no set-aside designation, covers the supply of Ofev (nintedanib) 100 mg capsules in a quantity of 60 units. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $68,724.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by October 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract specifies performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a quantity of 60 units, with a ceiling value of $8,630.28. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,590.58 by the Defense Logistics Agency on August 27, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed price delivery order with a completion date of September 18, 2025, and represents a non-set-aside competitive award. The contract will be fulfilled at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $51,662.58 on August 13, 2025, for the supply of Ofev 100 mg capsules (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 10, 2025, and performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract issued...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXVADelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a 60-count package, with a ceiling value of $17,181.16 and a completion date of September 23, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to deliver pharmaceuticals and medical supplies to military healthcare systems and other federal agencies worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's demonstrated capability to compete successfully for federal contracts across multiple therapeutic domains positions it as a key supplier for the Defense Health Agency and other federal healthcare systems. This particular delivery order for Ofev, a medication used in treating pulmonary fibrosis, reflects the company's role in supplying specialized pharmaceutical products to support military medical operations and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 9/2/25 |